Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT

NCT02376985 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

PROCEDURE: Oral management
DRUG: Everolimus

Sponsor

Comprehensive Support Project for Oncology Research

Collaborators

[object Object]